Case Series of End-Stage Liver Disease Patients with Severe Coccidioidomycosis

Daniel Ho1, Kristen D Kelley1, Satya Dandekar2

  • 1Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA.

Insights

Liver disease weakens the immune system, increasing risks for fungal infections like coccidioidomycosis. This study highlights severe coccidioidomycosis cases in patients with liver dysfunction, emphasizing the need for further research.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Hepatology

Background:

  • Liver disease compromises host immunity via multiple mechanisms.
  • It is a known risk factor for invasive fungal infections (e.g., candidiasis, cryptococcosis).
  • Immunologic compromise from liver dysfunction accelerates disease progression, increasing morbidity and mortality.

Purpose of the Study:

  • To describe cases of severe coccidioidomycosis in patients with liver dysfunction.
  • To highlight the potential link between liver disease and severe coccidioidomycosis outcomes.
  • To underscore the need for further investigation into this association.

Main Methods:

  • Case series description of severe coccidioidomycosis.
  • Analysis of patient data in the context of concurrent liver dysfunction.
  • Review of clinical presentations and outcomes.

Main Results:

  • Severe coccidioidomycosis was observed in patients with underlying liver dysfunction.
  • The presence of liver disease may exacerbate coccidioidomycosis severity.
  • This association warrants further epidemiological investigation.

Conclusions:

  • Liver dysfunction is associated with severe coccidioidomycosis.
  • Collaborative multi-center studies are needed to determine the incidence of severe coccidioidomycosis in patients with liver disease.
  • Understanding this relationship is crucial for patient management and public health strategies.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
295
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
58
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
394
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
289
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
390